Open Access
Editorial
Issue
Med Sci (Paris)
Volume 40, Number 10, Octobre 2024
Page(s) 705 - 706
Section Éditorial
DOI https://doi.org/10.1051/medsci/2024111
Published online 25 October 2024
  1. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006 ; 354 : 1264–72. [CrossRef] [PubMed] [Google Scholar]
  2. Kaplan H, Thompson RC, Trumble BC, et al. Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study. Lancet 2017 ; 389 : 1730–9. [CrossRef] [PubMed] [Google Scholar]
  3. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 ; 364 : 937–52. [CrossRef] [PubMed] [Google Scholar]
  4. Cholesterol Treatment Trialists’ (CTT) Collaboration, Fulcher J, O’Connell R, Voysey M, et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet 2015 ; 385 : 1397–405. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.